ERIS LIFESCIENCES LIMITED Q2 FY26 PAT stood at INR 134 Cr, up 39% YoY, with 17.0% PAT margin
AHMEDABAD, 13TH November: Eris Lifesciences Limited a leading Indian branded formulations manufacturing company, today announced its earnings for the quarter and half year ended September 30, 2025. Q2 and H1 FY2026 Financial Performance Summary (Consolidated): Particulars (INR Cr) Q2 FY26 Q2 FY25 YoY (%) H1 FY26 H1 FY25 YoY (%) Revenue from Operations 792 741…
